ScienceGate Book Chapters

JOURNAL ARTICLE

Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patients

Silvia Giunco Marta Padovan C. Angelini Francesco Cavallin Giulia Cerretti Marzia Morello Mario Caccese Beatrice Rizzo Domenico D’Avella Alessandro Della Puppa Franco Chioffi Pasquale De Bonis Vittorina Zagonel Anita De Rossi Giuseppe Lombardi

Year: 2023 Journal: ESMO Open Vol: 8 (3)Pages: 101570-101570 Publisher: Elsevier BV

DOI: 10.1016/j.esmoop.2023.101570

Get Full-Text PDF Get Analytical Report

Keywords:

Isocitrate dehydrogenase Telomere Telomerase reverse transcriptase Single-nucleotide polymorphism IDH1 Hazard ratio Promoter Oncology Telomerase Biology Internal medicine O-6-methylguanine-DNA methyltransferase Genotype Methyltransferase Methylation Wild type Cancer research Medicine Mutation Genetics Gene Confidence interval Enzyme Gene expression

Metrics

19

Cited By

7.14

FWCI (Field Weighted Citation Impact)

45

Refs

0.97

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Glioma Diagnosis and Treatment

Health Sciences → Medicine → Genetics

Epigenetics and DNA Methylation

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Ferroptosis and cancer prognosis

Health Sciences → Medicine → Pulmonary and Respiratory Medicine

Related Documents

JOURNAL ARTICLE

Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma

Takahiro Sasaki Manabu Kinoshita Koji Fujita Junya Fukai Nobuhide Hayashi Yuji Uematsu Yoshiko Okita Masahiro Nonaka Shusuke Moriuchi Takehiro Uda Naohiro Tsuyuguchi Hideyuki Arita Kanji Mori Kenichi Ishibashi Koji Takano Namiko Nishida Tomoko Shofuda Ema Yoshioka Daisuke Kanematsu Yoshinori Kodama Masayuki Mano Naoyuki Nakao Yonehiro Kanemura

Journal: Scientific Reports Year: 2019 Vol: 9 (1)Pages: 14435-14435

JOURNAL ARTICLE

PV-0503: Novel RPA classification combining MGMT promoter methylation status in newly diagnosed glioblastoma

Chan Woo Wee E. Kim I.A. Kim T.M. Kim Y.J. Kim C.K. Park J.W. Kim C.Y. Kim Serah Choi J.H. Kim S.H. Park Gheeyoung Choe S.T. Lee I.H. Kim

Journal: Radiotherapy and Oncology Year: 2017 Vol: 123 Pages: S265-S265

JOURNAL ARTICLE

BIOM-21. THE SIGNIFICANCE OF TERT PROMOTER MUTATIONS, TELOMERE LENGTH AND MGMT PROMOTER METHYLATION IN NEWLY DIAGNOSED AND RECURRENT IDH-WILDTYPE GLIOBLASTOMA (GBM): A LARGE MONO-INSTITUTIONAL STUDY

Giuseppe Lombardi Silvia Giunco Francesco Cavallin Chiara Angelini Mario Caccese Giulia Cerretti Pasquale De Bonis Anita De Rossi Vittorina Zagonel

Journal: Neuro-Oncology Year: 2021 Vol: 23 (Supplement_6)Pages: vi15-vi15

JOURNAL ARTICLE

363P Clinical significance of telomerase reverse transcriptase (TERT) promoter mutations, telomere length and MGMT promoter methylation status in newly diagnosed and recurrent IDHwildtype glioblastoma (GBM) patients (PTS): A large mono-institutional study

Giuseppe Lombardi Silvia Giunco Francesco Cavallin Chiara Angelini Mario Caccese Giulia Cerretti Pasquale De Bonis Anita De Rossi Vittorina Zagonel

Journal: Annals of Oncology Year: 2021 Vol: 32 Pages: S523-S523

JOURNAL ARTICLE

OS07.1 Molecular differences in IDH wild type glioblastoma according to MGMT promoter methylation status

Tobias Keßler Felix Sahm Ahmed Sadik Anne Hertenstein Martin Bendszus Andreas von Deimling Michael Platten Wolfgang Wick

Journal: Neuro-Oncology Year: 2017 Vol: 19 (suppl_3)Pages: iii12-iii13